Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Rheumatol. 2016 Jan 29;35(6):1493–1499. doi: 10.1007/s10067-016-3190-4

Table 3.

Predictors of first joint injection in patients with Juvenile Idiopathic Arthritis

Hazard ratio*
(95 % CI)
p-value
Age, years 1.06 (0.99, 1.13) 0.11
Male sex 1.44 (0.72, 2.87) 0.30
Calendar year of diagnosis 1.12 (1.05, 1.20) <0.001
JIA subtype – Polyarthritis (vs Oligoarthritis) 0.98 (0.36, 2.64)
JIA subtype – Undifferentiated (vs
Oligoarthritis)
0.98 (0.40, 2.41) 0.98
JIA subtype – Other (vs Oligoarthritis) 0.75 (0.17, 3.24)
Time from symptom onset to diagnosis,
months
1.02 (0.98, 1.07) 0.35
Presence at diagnosis - tenosynovitis 2.54 (0.75, 8.545 0.13
Hemoglobin at diagnosis 0.96 (0.67, 1.37) 0.82
Leukocytes at diagnosis 1.00 (1.00, 1.00) 0.067
ESR at diagnosis 1.00 (0.98, 1.02) 0.66
CRP at diagnosis (mg/L) 1.01 (0.99, 1.03) 0.42
ANA 2.58 (1.16, 5.74) 0.020
RF 1.18 (0.43, 3.25) 0.75
ACPA 1.03 (0.16, 6.84) 0.97
HLA B27 3.15 (0.28, 35.22) 0.35
*

Adjusted for age and sex. ACPA=anti-citrullinated peptide antibody. ANA=antinuclear antibody. CRP=C-reactive protein. ESR=Erythrocyte sedimentation rate. JIA=juvenile idiopathic arthritis. RF=rheumatoid factor.